X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-15 | STSS | Sharps Technology Inc. | Danner Paul K | Dir | P - Purchase | $20.00 | +5 | 5 | New | +$100 | ||||||
2025-07-15 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $85.17 | -2,750 | 59,602 | -4% | -$234,217 | ||||||
2025-07-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $86.03 | -500 | 94,602 | -1% | -$43,015 | ||||||
2025-07-11 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.65 | +8,536 | 16,290,730 | 0% | +$5,574 | ||||||
2025-07-10 | LYRA | Lyra Therapeutics, Inc. | Palasis Maria | Pres, CEO | S - Sale | $8.91 | -1,565 | 1,098,435 | 0% | -$13,944 | ||||||
2025-07-10 | LYRA | Lyra Therapeutics, Inc. | Cavalier Jason | CFO | S - Sale | $8.91 | -684 | 519,316 | 0% | -$6,094 | ||||||
2025-07-10 | ATEC | Alphatec Holdings, Inc. | Marshall Tyson Eliot | GC, CORP. SEC. | S - Sale | $12.00 | -1,500 | 469,301 | 0% | -$18,000 | ||||||
2025-07-10 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $12.00 | -3,982 | 744,936 | -1% | -$47,784 | ||||||
| D | 2025-07-09 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $243.75 | -15,985 | 712,014 | -2% | -$3,896,344 | |||||
| D | 2025-07-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $256.72 | -8,009 | 455,503 | -2% | -$2,056,076 | |||||
2025-07-03 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $4.17 | -9,160 | 266,321 | -3% | -$38,234 | ||||||
2025-07-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $4.10 | -19,260 | 617,468 | -3% | -$78,927 | ||||||
2025-07-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO | S - Sale | $4.15 | -23,637 | 5,986,943 | 0% | -$98,141 | ||||||
2025-07-03 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $4.17 | -5,679 | 1,831,025 | 0% | -$23,704 | ||||||
2025-07-02 | SGHT | Sight Sciences, Inc. | Link Matthew | Chief Commercial Officer | S - Sale | $4.10 | -4,889 | 832,293 | -1% | -$20,035 | ||||||
2025-07-07 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $18.26 | -757 | 793,188 | 0% | -$13,823 | ||||||
2025-07-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $18.34 | -5,005 | 217,078 | -2% | -$91,811 | ||||||
2025-07-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $18.27 | -3,310 | 279,121 | -1% | -$60,476 | ||||||
2025-07-02 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $18.29 | -3,127 | 261,681 | -1% | -$57,203 | ||||||
2025-07-02 | OFIX | Orthofix Medical Inc. | Engine Capital Management, LP | 10% | P - Purchase | $11.11 | +1,250 | 4,252,921 | 0% | +$13,881 | ||||||
2025-07-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $252.70 | -600 | 66,057 | -1% | -$151,622 | ||||||
2025-07-02 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $255.49 | -945 | 68,273 | -1% | -$241,438 | ||||||
2025-07-01 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.63 | +8,574 | 16,282,194 | 0% | +$5,384 | ||||||
| D | 2025-06-30 | ICU | Seastar Medical Holding Corp | Baird Jennifer A | Dir | P - Purchase | $0.42 | +10,000 | 28,000 | +56% | +$4,174 | |||||
| D | 2025-07-01 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $256.99 | -3,883 | 84,283 | -4% | -$997,892 | |||||
2025-07-02 | IRTC | Irhythm Technologies, Inc. | Turakhia Minang | EVP, CMO, CSO | S - Sale | $145.41 | -1,420 | 41,393 | -3% | -$206,482 | ||||||
| D | 2025-07-01 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $106.97 | -50,000 | 183,576 | -21% | -$5,348,315 | |||||
2025-07-01 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $256.99 | -66 | 8,536 | -1% | -$16,961 | ||||||
2025-06-30 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.62 | +1,347 | 16,273,620 | 0% | +$838 | ||||||
| AM | 2025-04-17 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $8.92 | +426 | 8,866,888 | 0% | +$3,799 | |||||
2025-06-26 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $85.06 | -1,466 | 108,155 | -1% | -$124,698 | ||||||
| D | 2025-06-25 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $253.40 | -15,890 | 700,023 | -2% | -$4,026,589 | |||||
2025-06-26 | OBIO | Orchestra Biomed Holdings, Inc. | Fain Eric S | Dir | S - Sale | $3.05 | -2,683 | 50,949 | -5% | -$8,183 | ||||||
2025-06-24 | ICU | Seastar Medical Holding Corp | Neuman John | Dir | P - Purchase | $0.36 | +40,000 | 80,000 | +100% | +$14,396 | ||||||
2025-06-23 | IRTC | Irhythm Technologies, Inc. | Wilson Daniel G. | CFO | S - Sale | $150.00 | -3,000 | 40,307 | -7% | -$450,000 | ||||||
2025-06-23 | IRTC | Irhythm Technologies, Inc. | Patterson Chad | Chief Commercial Officer | S - Sale | $150.00 | -936 | 48,929 | -2% | -$140,400 | ||||||
2025-06-18 | OFIX | Orthofix Medical Inc. | McPherron Aviva | Pres, Global Ops, Qual | S - Sale | $10.51 | -3,728 | 46,322 | -7% | -$39,181 | ||||||
2025-06-18 | SINT | Sintx Technologies, Inc. | Anderson Mark Lewis | Dir | P - Purchase | $3.30 | +10,000 | 15,000 | +200% | +$33,000 | ||||||
2025-06-16 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $259.78 | -50 | 5,373 | -1% | -$12,989 | ||||||
| M | 2025-06-17 | OGEN | Oragenics Inc | Odyssey Health, Inc. | 10% | S - Sale | $4.32 | -7,044 | 0 | -100% | -$30,407 | |||||
2025-06-16 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $83.13 | -2,750 | 62,352 | -4% | -$228,605 | ||||||
2025-06-16 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $82.80 | -500 | 95,102 | -1% | -$41,400 | ||||||
2025-06-17 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.66 | +21,687 | 16,272,273 | 0% | +$14,274 | ||||||
2025-06-17 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $29.50 | -15,000 | 64,200 | -19% | -$442,500 | ||||||
2025-06-13 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $11.07 | -22,727 | 748,918 | -3% | -$251,588 | ||||||
| D | 2025-06-13 | MMSI | Merit Medical Systems Inc | Parra Raul Jr. | CFO, Treasurer | S - Sale+OE | $93.75 | -15,181 | 26,937 | -36% | -$1,423,219 | |||||
| M | 2025-06-13 | DXCM | Dexcom Inc | Augustinos Nicholas | Dir | S - Sale | $82.34 | -6,290 | 38,457 | -14% | -$517,906 | |||||
| M | 2025-06-12 | PLSE | Pulse Biosciences, Inc. | Uecker Darrin | CTO | S - Sale | $16.19 | -30,000 | 122,872 | -20% | -$485,700 | |||||
2025-06-13 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $28.44 | -26,132 | 79,200 | -25% | -$743,131 | ||||||
2025-06-13 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | S - Sale | $2.57 | -3,000 | 129,053 | -2% | -$7,704 | ||||||
| M | 2025-06-13 | OGEN | Oragenics Inc | Odyssey Health, Inc. | 10% | S - Sale | $4.36 | -10,000 | 7,044 | -59% | -$43,600 | |||||
| D | 2025-06-13 | PODD | Insulet Corp | Singh Prem | SVP, Global Operations | S - Sale+OE | $300.05 | -2,327 | 4,143 | -36% | -$698,216 | |||||
2025-06-13 | PODD | Insulet Corp | Manea Dan | SVP, CHRO | S - Sale | $300.05 | -1,300 | 9,090 | -13% | -$390,065 | ||||||
2025-06-13 | ARAY | Accuray Inc | Whitters Joseph E | Dir | P - Purchase | $1.25 | +50,000 | 611,053 | +9% | +$62,335 | ||||||
2025-06-13 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.66 | +19,769 | 16,250,586 | 0% | +$13,014 | ||||||
| D | 2025-06-11 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $253.67 | -15,910 | 687,937 | -2% | -$4,035,890 | |||||
2025-06-12 | LUNG | Pulmonx Corp | Ferrari Richard | Dir | S - Sale | $3.16 | -8,000 | 87,024 | -8% | -$25,280 | ||||||
2025-06-11 | ATEC | Alphatec Holdings, Inc. | McGinnis Karen K | Dir | S - Sale | $12.11 | -3,963 | 68,709 | -5% | -$47,992 | ||||||
2025-06-11 | OFIX | Orthofix Medical Inc. | Reinhardt Max | Pres, Global Spine | S - Sale | $11.64 | -1,643 | 27,481 | -6% | -$19,125 | ||||||
| DM | 2025-06-10 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | S - Sale+OE | $62.93 | -75,000 | 22,766 | -77% | -$4,719,492 | |||||
2025-06-10 | CLPT | Clearpoint Neuro, Inc. | Richards Timothy T. | Dir | S - Sale | $13.28 | -10,000 | 77,381 | -11% | -$132,800 | ||||||
| D | 2025-06-10 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P. | Pres, CEO | S - Sale+OE | $95.61 | -400 | 1,151,344 | 0% | -$38,244 | |||||
2025-06-11 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.67 | +8,758 | 16,230,817 | 0% | +$5,862 | ||||||
2025-06-09 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale | $13.29 | -21,247 | 268,885 | -7% | -$282,373 | ||||||
| M | 2025-06-09 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $2.36 | -4,000 | 362,284 | -1% | -$9,439 | |||||
2025-06-10 | IRTC | Irhythm Technologies, Inc. | Patterson Chad | Chief Commercial Officer | S - Sale | $150.00 | -363 | 49,865 | -1% | -$54,450 | ||||||
| D | 2025-06-09 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $251.21 | -8,009 | 457,593 | -2% | -$2,011,910 | |||||
2025-06-09 | PODD | Insulet Corp | Borio Luciana | Dir | S - Sale | $305.73 | -481 | 3,087 | -13% | -$147,056 | ||||||
| D | 2025-06-05 | SNWV | Sanuwave Health, Inc. | Stegagno Peter | COO | S - Sale+OE | $27.71 | -1,862 | 2,032 | -48% | -$51,596 | |||||
| D | 2025-06-05 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P. | Pres, CEO | S - Sale+OE | $95.19 | -10,000 | 1,151,744 | -1% | -$951,900 | |||||
| M | 2025-06-04 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | Dir, 10% | P - Purchase | $4.22 | +90,525 | 7,097,340 | +1% | +$381,958 | |||||
| M | 2025-06-04 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $2.31 | -2,000 | 366,284 | -1% | -$4,613 | |||||
2025-06-05 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $19.05 | -3,377 | 129,767 | -3% | -$64,335 | ||||||
| M | 2025-06-04 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $12.34 | -200,000 | 1,450,018 | -12% | -$2,468,278 | |||||
| D | 2025-06-06 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale+OE | $64.13 | -20,000 | 63,133 | -24% | -$1,282,637 | |||||
2025-06-04 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $247.32 | -2,000 | 69,218 | -3% | -$494,640 | ||||||
2025-06-05 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | P - Purchase | $3.06 | +23,321 | 117,231 | +25% | +$71,362 | ||||||
| M | 2025-06-03 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | S - Sale | $62.16 | -75,000 | 89,363 | -46% | -$4,661,861 | |||||
2025-06-04 | OFIX | Orthofix Medical Inc. | Bazaar Alan Lee | Dir | P - Purchase | $10.92 | +2,250 | 30,983 | +8% | +$24,570 | ||||||
2025-06-03 | CLPT | Clearpoint Neuro, Inc. | Fallon Lynnette C | Dir | S - Sale | $12.57 | -10,200 | 40,901 | -20% | -$128,226 | ||||||
2025-06-04 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.58 | -10,000 | 261,491 | -4% | -$5,804 | ||||||
2025-06-04 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.66 | +8,000 | 16,222,059 | 0% | +$5,280 | ||||||
| D | 2025-06-04 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $102.88 | -56,372 | 183,576 | -23% | -$5,799,630 | |||||
2025-06-02 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $258.17 | -600 | 64,714 | -1% | -$154,903 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $17.89 | -868 | 34,132 | -2% | -$15,529 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | S - Sale | $17.89 | -1,039 | 72,032 | -1% | -$18,588 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $17.89 | -1,115 | 92,904 | -1% | -$19,948 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale | $17.89 | -1,497 | 45,503 | -3% | -$26,783 | ||||||
2025-06-02 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale | $17.89 | -3,439 | 104,561 | -3% | -$61,526 | ||||||
2025-06-02 | LUNG | Pulmonx Corp | Williamson Steven S. | Pres, CEO | S - Sale | $3.13 | -9,923 | 366,115 | -3% | -$31,059 | ||||||
2025-06-02 | LUNG | Pulmonx Corp | Joshi Mehul | CFO, PAO | S - Sale | $3.13 | -8,061 | 213,925 | -4% | -$25,231 | ||||||
2025-06-02 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $3.13 | -6,947 | 386,331 | -2% | -$21,748 | ||||||
2025-06-02 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $3.13 | -10,457 | 273,039 | -4% | -$32,736 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Stafford Kristin | Dir | S - Sale | $17.28 | -999 | 3,054 | -25% | -$17,259 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale | $17.31 | -999 | 81,229 | -1% | -$17,297 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Madden Martin J. | Dir | S - Sale | $17.19 | -999 | 18,674 | -5% | -$17,176 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Scannell Timothy J | Dir | S - Sale | $17.32 | -999 | 6,018 | -14% | -$17,299 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Hilleman Jeryl L | Dir | S - Sale | $17.26 | -999 | 5,591 | -15% | -$17,247 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Ocean Allyson J | Dir | S - Sale | $17.29 | -999 | 3,054 | -25% | -$17,269 | ||||||
2025-06-03 | NVCR | Novocure Ltd | Vernon W Anthony | Dir | S - Sale | $17.35 | -999 | 167,887 | -1% | -$17,329 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |